Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   The Bladder Tumor Suppressor Protein TERE1 (UBIAD1) Modulates Cell Cholesterol: Implications for Tumor Progression
  2. Fredericks, W. J.; McGarvey, T.; Wang, H. Y.; Lal, P.; Puthiyaveettil, R.; Tomaszewski, J.; Sepulveda, J.; Labelle, E.; Weiss, J. S.; Nickerson, M. L.; Kruth, H. S.; Brandt, W.; Wessjohann, L. A.; Malkowicz, S. B.
  3. DNA and Cell Biology. 2011, Nov; 30(11): 851-864.
  1. 2.   Identification of Potential Protein Targets of Isothiocyanates by Proteomics
  2. Mi, L. X.; Hood, B. L.; Stewart, N. A.; Xiao, Z.; Govind, S.; Wang, X. T.; Conrads, T. P.; Veenstra, T. D.; Chung, F. L.
  3. Chemical Research in Toxicology. 2011, Oct; 24(10): 1735-1743.
  1. 3.   Human Monoclonal Antibody Fragments Binding to Insulin-like Growth Factors I and II with Picomolar Affinity
  2. Zhao, Q.; Feng, Y.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2011, Sep; 10(9): 1677-1685.
  1. 4.   Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Colburn, N. H.; Cross, A. J.
  3. British Journal of Cancer. 2010, Oct; 103(9): 1453-1461.
  1. 5.   Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex
  2. Brooks, A. D.; Jacobsen, K. M.; Li, W. Q.; Shanker, A.; Sayers, T. J.
  3. Molecular Cancer Research. 2010, May; 8(5): 729-738.
  1. 6.   Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
  2. Norris, J. D.; Joseph, J. D.; Sherk, A. B.; Juzumiene, D.; Turnbull, P. S.; Rafferty, S. W.; Cui, H. X.; Anderson, E.; Fan, D. J.; Dye, D. A.; Deng, X.; Kazmin, D.; Chang, C. Y.; Willson, T. M.; McDonnell, D. P.
  3. Chemistry & Biology. 2009 16(4): 452-460.
  1. 7.   Proteomic analysis of protein expression changes in a model of gliomagenesis
  2. McBee, J. K.; Yu, L. R.; Kinoshita, Y.; Uo, T.; Beyer, R. P.; Veenstra, T. D.; Morrison, R. S.
  3. Proteomics Clinical Applications. 2007, Nov; 1(11): 1485-1498.
  1. 8.   Increased tumor growth in mice with diet-induced obesity: Impact of ovarian hormones
  2. Yakar, S.; Nunez, N. P.; Pennisi, P.; Brodt, P.; Sun, H.; Fallavollita, L.; Zhao, H.; Scavo, L.; Novosyadlyy, R.; Kurshan, N.; Stannard, B.; East-Palmer, J.; Smith, N. C. P.; Perkins, S. N.; Fuchs-Young, R.; Barrett, J. C.; Hursting, S. D.; LeRoith, D.
  3. Endocrinology. 2006, Dec; 147(12): 5826-5834.
  1. 9.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 10.   The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation
  2. Asefa, B.; Klarmann, K. D.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Keller, J. R.
  3. Blood Cells Molecules and Diseases. 2004, JAN-FEB; 32(1): 155-167.
  1. 11.   Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XLAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database
  2. Nikolovska-Coleska, Z.; Xu, L.; Hu, Z. J.; Tomita, Y.; Li, P.; Roller, P. P.; Wang, R. X.; Fang, X. L.; Guo, R. B.; Zhang, M. C.; Lippman, M. E.; Yang, D. J.; Wang, S. M.
  3. Journal of Medicinal Chemistry. 2004 47(10): 2430-2440.
  1. 12.   Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents
  2. Zhu, J. X.; Song, X. Q.; Lin, H. P.; Young, D. C.; Yan, S. Q.; Marquez, V. E.; Chen, C. S.
  3. Journal of the National Cancer Institute. 2002 94(23): 1745-1757.
  1. 13.   Deficient Expression of Mrna For the Putative Inductive Factor Bone Morphogenetic Protein-7 in Chemically Initiated Rat Nephroblastomas
  2. Higinbotham, K. G.; Karavanova, I. D.; Diwan, B. A.; Perantoni, A. O.
  3. Molecular Carcinogenesis. 1998 23(2): 53-61.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel